“Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the MecA Gene in Methicillin-Resistant Staphylococcus Aureus: A Novel Approach to Reverse Antibiotic Resistance”. 2026. Wah Academia Journal of Health and Nutrition 2 (2): 27-35. https://doi.org/10.63954/bantev40.